BPMC - Blueprint Medicines EPS beats by $0.06 beats on revenue February, 17 2021 07:08 AM Blueprint Medicines Corporation Blueprint Medicines (BPMC): Q4 GAAP EPS of -$1.53 beats by $0.06.Revenue of $34.11M (-33.8% Y/Y) beats by $3.36M.Press Release For further details see: Blueprint Medicines EPS beats by $0.06, beats on revenue